JTCS Speed Up Your Browser
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wisoff, B. G.
Right arrow Articles by Hamby, R. I.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wisoff, B. G.
Right arrow Articles by Hamby, R. I.

The Journal of Thoracic and Cardiovascular Surgery, Vol 69, 669-673, Copyright © 1975 by The American Association for Thoracic Surgery and The Western Thoracic Surgical Association


ARTICLES

Risk of coronary surgery. Two hundred consecutive patients with no hospital deaths

BG Wisoff, ML Hartstein, A Aintablian and RI Hamby

Revascularization surgery must carry a low morbidity and mortality rate to be a valid alternative treatment of obstructive coronary disease. A consecutive series of 200 patients underwent coronary bypasses at LIJ- HMC. The average age was 53.9 years (33 to 77) with 81.5 per cent of the patients men. Clinical presentation was as follows: 28 per cent were in New York Heart Association Class III and 72 per cent in Class IV (or unstable). Previous infarctions were documented in 37 per cent. Sixteen patients (8 per cent) had disease of the main left coronary artery. Single bypasses were placed in 37.5 per cent, double in 40.5 per cent, and triple or quadruple in 22 per cent. The rate of vein graft patency was 95.3 per cent (245 of 257 studied grafts). There were no hospital deaths in this consecutive group of 200 patients. There have been two late deaths after an average follow-up period of 16 months.


This article has been cited by other articles:


Home page
Eur. J. Cardiothorac. Surg.Home page
J. Dunning, M. Versteegh, A. Fabbri, A. Pavie, P. Kolh, U. Lockowandt, S. A.M. Nashef, and on behalf of the EACTS Audit and Guidelines Commit
Guideline on antiplatelet and anticoagulation management in cardiac surgery.
Eur. J. Cardiothorac. Surg., July 1, 2008; 34(1): 73 - 92.
[Abstract] [Full Text] [PDF]


Home page
ICVTSHome page
V. Close, M. Purohit, M. Tanos, and S. Hunter
Should patients post-cardiac surgery be given low molecular weight heparin for deep vein thrombosis prophylaxis?
Interactive CardioVascular and Thoracic Surgery, October 1, 2006; 5(5): 624 - 629.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 1975 by The American Association for Thoracic Surgery.